Funding
Series C · Healthtech

Iterative Health raises $77m Series C for clinical research

Intrepid Growth Partners, GV, EDBI, Insight Partners and Obvious Ventures participated in the financing.

Updated Oct 16, 2026By RoundOS Funding desk

Iterative Health raised $77 million in Series C financing on April 30. Participants included Intrepid Growth Partners, GV, EDBI, Insight Partners and Obvious Ventures. The company develops technology and services for clinical research.

Funding history

Series C · This round$77M

Sources

  1. Iterative Healthprojectstartups.com
  2. businesswire.com

Similar rounds

All Healthtech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026

Related